Federica Bovo

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Multidrug Resistant

Cystic Fibrosis

Loop Mediated Isothermal Amplification

Top Venues

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Palombo, Benedetta Secci, Federica Bovo, Milo Gatti, Simone Ambretti, Paolo Gaibani
In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing Klebsiella pneumoniae Clinical Isolates. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Federica Bovo, Lazzarotto Tiziana, Simone Ambretti, Paolo Gaibani
Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae . Antibiotics (Basel, Switzerland) 12 (3) (2023)
Marta Palombo, Federica Bovo, Stefano Amadesi, Paolo Gaibani
Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria. Antibiotics (Basel, Switzerland) 12 (5) (2023)
Marta Palombo, Benedetta Secci, Federica Bovo, Milo Gatti, Simone Ambretti, Paolo Gaibani
In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing Klebsiella pneumoniae Clinical Isolates. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Federica Bovo, Lazzarotto Tiziana, Simone Ambretti, Paolo Gaibani
Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae . Antibiotics (Basel, Switzerland) 12 (3) (2023)
Paolo Gaibani, Tommaso Giani, Federica Bovo, Donatella Lombardo, Stefano Amadesi, Lazzarotto Tiziana, Marco Coppi, Gian Maria Rossolini, Simone Ambretti
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing. Antibiotics (Basel, Switzerland) 11 (5) (2022)
Federica Bovo, Donatella Lombardo, Lazzarotto Tiziana, Simone Ambretti, Paolo Gaibani
Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC -Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020. Antibiotics (Basel, Switzerland) 11 (11) (2022)